Peptidream Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Peptidream Inc with three other
companies in this sector in Japan:
Sosei Group Corporation
sales of 6.96 billion Japanese Yen [US$61.76 million]
of which 100%
Linical Company Limited
(9.11 billion Japanese Yen [US$80.92 million]
of which 90%
was Cro Business), and
Trans Genic Inc
(3.60 billion Japanese Yen [US$31.98 million]
of which 42%
was TGBS business).
During the year ended June of 2018, sales at
Peptidream Inc were ¥6.43 billion (US$57.07 million).
increase of 31.3%
versus 2017, when the company's sales were ¥4.90 billion.
This was the fifth consecutive year of sales increases at Peptidream Inc
(and since 2013, sales have increased a total of 848%).